The Patent Finder
NT

Neuropro Therapeutics, Inc.

First filing 2005
OverviewNotableFeesChangesFamiliesPatent listSources & methods

Three patents currently held, every record listed here

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

The next term ends in Aug 2028. from the record

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
2
Ending by 2030
Aug 2028
Next term end
3
Patent families

When these terms end

Each bar runs from grant to computed term end. 2011 to 2037.
US 8,008,283 Methods and Compositions for the Treatment of Neuropsychiatric Disorders Aug 27, 2028
US 9,682,928 Bumetanide Analogs, Compositions and Methods of Use Jan 22, 2030
US 12,020,953 Fan-Out Structure and Method of Fabricating the Same Aug 16, 2037
201620212026203120362037
4 pending applications: term is not computable until grant.Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know

Patents held now

Soonest term end first.

Showing 1 to 3 of 3

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatusExpiresConfidence
US 8,008,283Methods and Compositions for the Treatment of Neuropsychiatric Disorders
In force
 · High confidence
In forceHigh confidence
US 9,682,928Bumetanide Analogs, Compositions and Methods of Use
In force
 · Medium confidence
In forceMedium confidence
US 12,020,953Fan-Out Structure and Method of Fabricating the Same
In force
 · Medium confidence
In forceMedium confidence
Also on record, not counted in the 3: 1 patent ended · 4 applications pending · 9 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
3 computed term dates come from a chain with an unresolved parent. A continuity parent has not yet been fetched from USPTO's records. The term is dated from this application's own claim; no earlier date is assumed until the parent is resolved.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited